Inspira Technologies Oxy B.H.N. Ltd. is a pioneering medical technology company focused on developing advanced oxygen delivery systems aimed at improving respiratory support for critically ill patients. The company plays a vital role in the rapidly expanding medical device sector, driven by increasing global demand for innovative respiratory therapies. By addressing the critical challenges in patient care, Inspira Technologies positions itself as a compelling investment opportunity for institutional investors looking to engage in the transformative landscape of healthcare advancements.
| Revenue (TTM) | 289,000 |
| Gross Profit (TTM) | 2,000 |
| EBITDA | $-13.47M |
| Operating Margin | -4714.00% |
| Return on Equity | -397.90% |
| Return on Assets | -127.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.07 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $32.37M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |